Ranibizumab

Ranibizumab is used for diabetic eye disease, wet age-related macular degeneration and Macular edema due to retinal vein occlusion.

Ranibizumab is an anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the growth and leakage of abnormal blood vessels in the eye(s) that may cause vision loss.

Conjunctival hemorrhage, Eye pain, Increased intraocular pressure, Foreign body sensation in eyes, Blurred vision, Nausea, Dry eye, Eye itching, Cataract, Vitreous floaters, Vitreous detachment, Intraocular inflammation, Eye irritation, Increased lacrimation, Eyelid inflammation, Ocular hyperemia, Retinal disorder, Maculopathy, Eye discomfort, Posterior capsule opacification, Injection site hemorrhage, Nasopharyngitis (inflammation of the throat and nasal passages), Anemia (low number of red blood cells), Joint pain, Renal failure, Peripheral neuropathy (tingling and numbness of feet and hand), Gastro-esophageal reflux disease, Hypercholesterolemia (high cholesterol), Bronchitis (inflammation of the airways)